LUPIN LTD. - Received final USFDA approval for ANDA Moxifloxacin Hydrochloride Tablets

Download	< Back
16 Feb 2017
Lupin Ltd has informed BSE that the Company has received final USFDA approval for ANDA Moxifloxacin Hydrochloride Tablets, 400 mg. Generic of Avlox Tablets of Bayer Healthcare Pharmaceuticals, Inc.
View all announcements for LUPIN LTD.	Source: BSE India

ALL MONEYWIZ PAGES

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us